Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that’s what a research group is discovering. ‘We have observed that an enzyme in cerebrospinal fluid and in blood is a useful marker for identifying all types of Parkinson’s-related diseases with high accuracy,’ says the study leader.